drugset
drugset / Trial / NCT01797185

Safety Study of SPARC1104

NCT01797185 ↗

Phase 3 Completed 375 enrolled Sun Pharma Advanced Research Company Limited
RandomizedParallel-groupOpen-labelOther

Summary

Open-label, safety study of SPARC1104 in subjects with spasticity due to multiple sclerosis

Timeline

Start
2013-04-09
Primary completion
2017-07
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject SPARC1104 Unknown — —

Indications

No indication recorded.